Repository hosted by TU Delft Library

Home · Contact · About · Disclaimer ·
 

Search results also available in MS Excel format.

Showing 1 to 3 of 3 found. | Sort by date

1 Review article: the role of butyrate on colonic function
article 2008    
Author: Hamer, H.M. · Jonkers, D. · Venema, K. · Vanhoutvin, S. · Troost, F.J. · Brummer, R.J.
Keywords: Nutrition Biology · Biomedical Research · Butyric acid · Corticosteroid · Enema · Histone deacetylase inhibitor · Immunoglobulin enhancer binding protein · Inulin · Ispagula · Mesalazine · Short chain fatty acid · Carcinogenesis · Colitis · Colon carcinogenesis · Colon mucosa · Combination chemotherapy · Deacetylation · Intestine mucosa permeability · Monotherapy · Proctitis · Satiety · Ulcerative colitis · Butyrates · Carbohydrate Metabolism · Colonic Neoplasms · Dietary Fiber · Fatty Acids, Volatile · Inflammation · Intestinal Mucosa · Oxidative Stress · Satiation
[Abstract]

2 Release of 5-aminosalicylate from an MMX mesalamine tablet during transit through a simulated gastrointestinal tract system
article 2007    
Author: Tenjarla, S. · Romasanta, V. · Zeijdner, E. · Villa, R. · Moro, L.
Keywords: Biology · Biomedical Research · 5-Aminosalicylate · Bioaccessibility · Gastrointestinal system · In vitro · Mesalamine · MultiMatrix System · Ulcerative colitis · mesalazine · mezavant · nonsteroid antiinflammatory agent · adult · article · controlled study · dialysis · drug clearance · drug coating · drug release · gastrointestinal transit · human · human experiment · in vitro study · normal human · tablet formulation · upper gastrointestinal tract · biological model · chemistry · delayed release formulation · gastrointestinal tract · kinetics · pH · pharmaceutics · Anti-Inflammatory Agents, Non-Steroidal · Delayed-Action Preparations · Gastrointestinal Tract · Hydrogen-Ion Concentration · Kinetics · Mesalamine · Models, Biological · Technology, Pharmaceutical
[Abstract]

3 Effect of the anti-tumor necrosis factor-α antibody infliximab on the ex vivo mucosal matrix metalloproteinase-proteolytic phenotype in inflammatory bowel disease
article 2007    
Author: Meijer, M.J. · Mieremet-Ooms, M.A.C. · Duijn, W. van · Zon, A.M. van der · Hanemaaijer, R. · Verheijen, J.H. · Hogezand, R.A. van · Lamers, C.B.H.W. · Verspaget, H.W.
Keywords: Biomedical Research · Inflammatory bowel disease · Infliximab · Matrix metalloproteinase · Tissue inhibitor of metalloproteinase · Tumor necrosis factor-alpha · azathioprine · cyclosporin · gelatinase A · gelatinase B · infliximab · interstitial collagenase · mesalazine · messenger RNA · pokeweed mitogen · steroid · stromelysin · tissue inhibitor of metalloproteinase 1 · tissue inhibitor of metalloproteinase 2 · tumor necrosis factor alpha antibody · adolescent · adult · aged · article · clinical article · controlled study · Crohn disease · drug effect · enteritis · explant · female · genotype · human · human tissue · intestine mucosa · male · priority journal · protein degradation · protein expression · single nucleotide polymorphism · ulcerative colitis · Adolescent · Adult · Aged · Antibodies, Monoclonal · Colitis, Ulcerative · Crohn Disease · Down-Regulation · Female · Humans · Intestinal Mucosa · Male · Matrix Metalloproteinases · Middle Aged · Phenotype · Polymorphism, Single Nucleotide · Reverse Transcriptase Polymerase Chain Reaction · Tissue Culture Techniques · Tissue Inhibitor of Metalloproteinases · Tumor Necrosis Factor-alpha
[Abstract]

Search results also available in MS Excel format.

Showing 1 to 3 of 3 found. | Sort by date